RCKT Rocket Pharmaceuticals, Inc.
Healthcare$3.00+1.35%ClosedMarket Cap: $327.6M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
1.39
P/S
0.00
EV/EBITDA
-1.52
DCF Value
$0.47
FCF Yield
-55.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-70.8%
ROA
-73.4%
ROIC
-81.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-48.5M | $-47.6M | $— | — |
| Q4 null | $0.00 | NaN% | $-44.0M | $-42.5M | $— | — |
| FY null | $0.00 | -Infinity% | $-228.5M | $-223.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-52.2M | $-50.3M | $— | — |
| Q2 null | $0.00 | NaN% | $-71.1M | $-68.9M | $— | — |
| Q1 null | $0.00 | NaN% | $-64.4M | $-61.3M | $— | — |
| Q4 null | $0.00 | NaN% | $-62.7M | $-60.3M | $— | — |
| FY null | $0.00 | NaN% | $-273.2M | $-258.7M | $— | — |
| Q3 null | $0.00 | NaN% | $-69.4M | $-66.7M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-73.7M | $-69.6M | $— | — |
| Q1 null | $0.00 | -Infinity% | $-67.4M | $-62.1M | $— | — |
| Q4 2023 | $0.00 | NaN% | $-63.3M | $-59.7M | $-0.64 | — |